Hester Biosciences Share Price

Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.As of 25 Jun 2026, Hester Biosciences share price is ₹2,252.20. The stock opened at ₹2,154.10, compared to its previous close of ₹2,116.60. During today's trading session, Hester Biosciences share price moved in the range of ₹2,121.10 to ₹2,287.70, with an average price of ₹2,204.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,121.10 and a high of ₹2,287.70. On the performance front, Hester Biosciences share price has increased by 41.43% over the last six months and is up 24.11% on a year-on-year basis.

The market capitalization of Hester Biosciences is ₹1,791 Crs, with a P/E ratio of 19.3 and a dividend yield of 0.87%.